Azienda Sanitaria Locale Napoli 2 Nord
Clinical trials sponsored by Azienda Sanitaria Locale Napoli 2 Nord, explained in plain language.
-
Weight-loss drug before hernia surgery cuts complications in obese patients
Disease control CompletedThis study tested a 16-week weight-loss program using the drug tirzepatide before elective hernia surgery in 91 adults with obesity. Participants lost an average of 13.8% of their body weight, and all reached the target weight needed for surgery. Compared to a similar group who h…
Sponsor: Azienda Sanitaria Locale Napoli 2 Nord • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Botox before hernia surgery: a simpler, safer repair?
Symptom relief CompletedThis study looked at whether injecting botulinum toxin A (like Botox) into the abdominal muscles before surgery can make it easier to close complex incisional hernias. The idea is that relaxing the muscles allows doctors to repair the hernia without needing more extensive procedu…
Sponsor: Azienda Sanitaria Locale Napoli 2 Nord • Aim: Symptom relief
Last updated Jun 27, 2026 08:13 UTC
-
Weight-Loss drug shows promise for regain after gastric sleeve
Knowledge-focused CompletedThis completed study looked at how tirzepatide, a weight-loss drug, works in real-world settings for two groups: people who regained weight after gastric sleeve surgery, and those preparing for obesity surgery. Researchers tracked weight and metabolic changes over 6 months in 254…
Sponsor: Azienda Sanitaria Locale Napoli 2 Nord • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:01 UTC